MCK Q2 2024 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q2 2024 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$77.2B+10.1% YoY

Gross Profit

$2.9B3.8% margin

Operating Income

$898M1.2% margin

Net Income

$664M0.9% margin

EPS (Diluted)

$4.93

QoQ Revenue Growth

+3.7%

Cash Flow

Operating Cash Flow

$965M

Free Cash Flow

$825M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$66.1B

Total Liabilities

$67.6B

Stockholders' Equity

-$1.8B

Cash & Equivalents

$2.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$77.2B	$70.2B	+10.1%
Gross Profit	$2.9B	$3.0B	-3.6%
Operating Income	$898M	$1.1B	-21.6%
Net Income	$664M	$926M	-28.3%

Revenue Segments

U.S. Pharmaceutical Segment

$69.8B90%

International Segment

$3.5B5%

Medical-Surgical Solutions Segment

$2.8B4%

Prescription Technology Solutions

$1.1B1%